HOME >> MEDICINE >> NEWS
ROZEREM (ramelteon) shown to be effective in a first-night-effect model of transient

Salt Lake City Data presented at the SLEEP 2006 20th Anniversary Meeting of the Associated Professional Sleep Societies have shown that ROZEREMTM (ramelteon) reduced time to fall asleep with no evidence of next-day residual effects, including psychomotor and memory effects, in a first-night-effect model of transient insomnia. The results of this double-blind, randomized study were presented as a poster presentation.

"Some medications taken for sleep are associated with lingering effects the next day, which could make performing activities requiring mental sharpness difficult or dangerous," said Gary Zammit, PhD, Director, Sleep Disorders Institute at St. Luke's-Roosevelt Hospital, New York. "These data suggest that ROZEREM can promote sleep in patients with transient insomnia without evidence of next-day psychomotor or memory effects."

Study Design
A total of 289 healthy adults were randomized to receive either ROZEREM 8 mg, 16 mg, or placebo 30 minutes before bedtime in this double-blind, parallel-group study designed to evaluate the efficacy of ROZEREM in a first-night-effect model of transient insomnia. Sleep was assessed with overnight polysomnography (PSG) a test that records brain activity and other body functions during sleep and a patient questionnaire completed the following morning. Patients also completed next-morning residual-effect assessments evaluating potential residual psychomotor or memory impairment.

Results found that ROZEREM was not associated with next-morning residual effects, as measured by Digit Symbol Substitution Test, memory tests for immediate and delayed recall, and visual analog scales that rate patient reports of mood and feeling. Adverse event rates were 12.4 percent, 13.3 percent, and 6.4 percent for the placebo, ROZEREM 8 mg, and ROZEREM 16 mg groups, respectively, with no clinically meaningful changes in laboratory value, vital sign, or electrocardiogram results observed.

The st
'"/>

Contact: Jocelyn M. Gerst
847-769-6889
Ketchum
19-Jun-2006


Page: 1 2

Related medicine news :

1. ROZEREM (ramelteon) showed significant reduction in time to fall asleep
2. FDA approved ROZEREM (ramelteon)
3. Pro-vitamin E shown to be active against breast cancer cells
4. Ultra low-dose estrogen shown safe for post-menopausal women
5. Radiation therapy shown to increase survival in certain lung cancer patients
6. AMITIZA(TM) (lubiprostone) shown effective and well-tolerated in people older than age 65
7. Drug shown to provide much needed alternative therapy for chronic shoulder pain
8. Nexium shown to reduce gastric ulcers in at-risk patients using long-term NSAIDS
9. State board-disciplined physicians more likely to have shown unprofessional behavior in med school
10. Technology for successful aging shown at White House conference
11. Stress echo tests shown to predict cardiac death, illness in higher-risk women

Post Your Comments:
(Date:5/19/2013)... (HealthDay News) -- Although spring arrived late this year ... season will still be strong, according to a sinus ... Dr. Richard Waguespack, clinical professor in the university,s division ... a robust summer allergy season. However, some simple strategies ... and coughing, he added. "Tree pollen has been ...
(Date:5/19/2013)... Springs, FL (PRWEB) May 19, 2013 Omaha, ... It is also a city with one of the lowest ... ranking it eleventh in their Best Places for Business and ... for Relocation lists. Omaha is centrally located in the ... stalwarts of industry located there. The producers of Editions ...
(Date:5/19/2013)... May 19, 2013 Today, Zane ... small business health insurance . Zane Benefits, which ... sponsored health benefits, is the leader in health ... health reimbursement arrangements . , According to Zane ... self-employed intrinsically know the value of small business ...
(Date:5/19/2013)... The report “Feed Additives Market by ... up to 2017” published by MarketsandMarkets, defines and segments ... forecasting of the global volume and revenue for the ... restraining factors for the global market with analysis of ... market is segmented and revenue is forecasted on the ...
(Date:5/19/2013)... Dr. Keith Chertok now provides gum disease patients ... and increase the chance of a healthier smile. Laser ... (LANAP) not only removes diseased gum tissue in patients, but ... for dental implants. , LANAP uses a laser ... also help stimulate the healthy tissue as well as encourage ...
Breaking Medicine News(10 mins):Health News:Managing Seasonal Allergies 2Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2
(Date:5/17/2013)... Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) ... new, patent-pending technologies poised to redefine how consumers receive energy, ... a business update teleconference and webcast for shareholders and the ... 4:30 PM ET. Fuse Science, Inc. CEO, ... and will be joined by Rubin Hanan ...
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/17/2013)... 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will release its ... 2013, before market on Tuesday, May 28, 2013.  The Company ... at 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. ... provide an update on recent corporate developments. To ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3
Cached News: